Amoéba S.A. (FRA:A1H)

Market Cap	60.28M
Revenue (ttm)	682.46K
Net Income (ttm)	-7.36M
Shares Out	n/a
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	733
Average Volume	139
Open	0.8710
Previous Close	0.8740
Day's Range	0.8710 - 0.8710
52-Week Range	0.7510 - 1.3360
Beta	n/a
RSI	38.54
Earnings Date	Dec 30, 2025

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.

• Industry: Miscellaneous Chemical Products
• Founded: 2010
• Employees: 20
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A1H

Financial Performance

In 2024, Amoéba's revenue was 601,600, a decrease of -9.44% compared to the previous year's 664,310. Losses were -6.59 million, -53.90% less than in 2023.